Congenital cataract does not greatly affect quality of life in young adults

Article

History of congenital cataract does not affect quality of life or educational achievements in adolescents and young adults.

History of congenital cataract does not affect quality of life or educational achievements in adolescents and young adults, claims a study in the Journal of Paediatric Ophthalmology and Strabismus.

Dr Caitriona Kirwan et al., Mater Private Hospital, Dublin, Ireland, performed a retrospective chart review on patients who underwent cataract surgery below the age of 24 months. The National Eye Institute 25-item Visual Function Questionnaire (NEI-VFQ-25) was used to assess vision-specific health-related quality of life in adolescents and young adults. A control group of healthy volunteers with no visual complaints was also included in the study.

Unilateral cataract was recorded in 16 patients, bilateral cataract in 22 patients and 15 people were in the control group. The bilateral participants experienced greater difficulty with regards to near and distance activities, compared to the unilateral group.

Between the unilateral and control group there were no significant differences in ocular pain, vision-specific social functioning, role difficulties and dependency scores. All patients attended main-stream school and the majority had attended university, meaning educational achievements were high in both cataract groups.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.